Vanguard Group Inc. Grows Position in Amedisys, Inc. (NASDAQ:AMED)

Vanguard Group Inc. raised its position in Amedisys, Inc. (NASDAQ:AMED - Free Report) by 0.3% during the 4th quarter, according to its most recent filing with the SEC. The firm owned 3,216,120 shares of the health services provider's stock after buying an additional 10,817 shares during the quarter. Vanguard Group Inc. owned about 9.82% of Amedisys worth $291,992,000 as of its most recent filing with the SEC.

A number of other large investors also recently bought and sold shares of the company. Blue Trust Inc. increased its stake in shares of Amedisys by 55.1% during the fourth quarter. Blue Trust Inc. now owns 349 shares of the health services provider's stock worth $34,000 after acquiring an additional 124 shares during the period. HBW Advisory Services LLC acquired a new position in Amedisys during the 4th quarter worth approximately $38,000. Versant Capital Management Inc raised its stake in shares of Amedisys by 68.5% during the 4th quarter. Versant Capital Management Inc now owns 450 shares of the health services provider's stock worth $41,000 after buying an additional 183 shares in the last quarter. Vestcor Inc purchased a new position in shares of Amedisys during the 4th quarter worth approximately $73,000. Finally, Venturi Wealth Management LLC lifted its holdings in shares of Amedisys by 397.4% in the 4th quarter. Venturi Wealth Management LLC now owns 975 shares of the health services provider's stock valued at $89,000 after buying an additional 779 shares during the period. Hedge funds and other institutional investors own 94.36% of the company's stock.

Analyst Upgrades and Downgrades

Separately, Stephens reaffirmed an "equal weight" rating and set a $101.00 price objective on shares of Amedisys in a report on Tuesday, March 4th. Four equities research analysts have rated the stock with a hold rating and one has issued a buy rating to the stock. According to MarketBeat.com, Amedisys presently has an average rating of "Hold" and a consensus price target of $101.00.

Remove Ads

Amedisys Price Performance

Shares of AMED stock traded up $0.72 during midday trading on Wednesday, reaching $92.03. 459,691 shares of the company traded hands, compared to its average volume of 399,890. The firm's 50 day simple moving average is $92.23 and its two-hundred day simple moving average is $92.13. The firm has a market cap of $3.02 billion, a PE ratio of 36.52, a price-to-earnings-growth ratio of 1.78 and a beta of 0.89. The company has a debt-to-equity ratio of 0.05, a current ratio of 1.19 and a quick ratio of 1.19. Amedisys, Inc. has a 1-year low of $82.15 and a 1-year high of $98.95.

Amedisys (NASDAQ:AMED - Get Free Report) last issued its quarterly earnings data on Wednesday, February 26th. The health services provider reported $0.96 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.05 by ($0.09). The firm had revenue of $598.05 million for the quarter, compared to analyst estimates of $602.38 million. Amedisys had a return on equity of 12.20% and a net margin of 3.57%. On average, equities research analysts expect that Amedisys, Inc. will post 4.4 EPS for the current fiscal year.

About Amedisys

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.